MHRA (Medicines and Healthcare products Regulatory Agency) formalises UK recall of ACS (Access CardioSystems) defibs:
This article was originally published in Clinica
Executive Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has echoed the worldwide recall of defibrillators manufactured by Access CardioSystems (ACS). The recall affects the Access AED, Access PAD, and Access ALS devices with serial numbers in the range 075180-084760. The MHRA reports two forms of potential failure, relating to the devices' inability to deliver more than one defibrillation shock and problems associated with the unexpected activation of the device (see Clinica No 1133, p 16). UK healthcare providers are urged to contact RL Dolby & Co (Stirling, Scotland), the UK distributor of the affected devices, for further details.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.